In a major crackdown on non-compliant drug manufacturing in Maharashtra, the FDA suspends 63 licenses and seizes over ₹26 ...

A new report reveals that delays in incident reporting and resolution are severely impacting productivity in Indian ...

The FDA has flagged serious data integrity lapses and unsanitary conditions at pharmaceutical units in India, urging ...

Glenmark Pharmaceuticals reports a staggering 56.7% decline in net profit to ₹264 crore for Q2 FY27, with a 29.8% drop in ...

Dr Reddy’s Laboratories has received marketing approval from Brazil’s ANVISA for its generic semaglutide injection, aimed at ...

Aurobindo Pharma is strategically expanding its respiratory care segment in the US by launching a generic asthma inhaler, ...

The Union Health Ministry of India is revising microbial contamination thresholds for sterile drugs, aligning them with WHO ...

New research reveals GLP-1 drugs significantly lower the risk of type 2 diabetes and cardiovascular issues compared to ...

Novo Nordisk increases its 2026 sales outlook for the third time this year, showcasing growth in Wegovy pill sales and its ...

Sino Biopharmaceutical has partnered with Boehringer Ingelheim in a $7 billion agreement for six preclinical oncology ...

Bengaluru: The US Food and Drug Administration has approved Inovio Pharmaceuticals' treatment for a rare respiratory condition, the regulator said on Friday, marking the company's first approved ...

Lupin Pharmaceuticals aims to leverage Bristol Myers Squibb's blood thinner Eliquis (apixaban) to counterbalance the ...